首页 | 本学科首页   官方微博 | 高级检索  
检索        

美罗培南治疗医院感染的临床研究
引用本文:金阳,辛建保,傅玲,张建初,李元桂,白明.美罗培南治疗医院感染的临床研究[J].中华医院感染学杂志,2005,15(10):1177-1180.
作者姓名:金阳  辛建保  傅玲  张建初  李元桂  白明
作者单位:华中科技大学同济医学院附属协和医院,湖北,武汉,430022
摘    要:目的评价美罗培南治疗医院感染的临床疗效和安全性. 方法选择中、重度医院感染患者,治疗组给予美罗培南0.5 g,q8h,静脉滴注;对照组给予亚胺培南/西司他丁1.0 g,q8h,静脉滴注;两药疗程均为7~10 d. 结果美罗培南组和亚胺培南/西司他丁组的临床痊愈率分别为48.5%和54.8%;临床有效率分别为81.8%和87.1%;细菌清除率分别为90.0%和86.4%;不良反应发生率分别为9.1%和6.5%;以上指标差异均无显著性(P>0.05). 结论美罗培南治疗医院感染是有效和安全的,与亚胺培南/西司他丁相比差异无显著性.

关 键 词:美罗培南  治疗  医院感染
文章编号:1005-4529(2005)10-1177-04
收稿时间:2004-02-16
修稿时间:2005-02-26

Meropenem in Treatment of Hospital Acquired Infection
JIN Yang,XIN Jian-bao,FU Ling,ZHANG Jian-chu,LI Yuan-gui,BAI Ming.Meropenem in Treatment of Hospital Acquired Infection[J].Chinese Journal of Nosocomiology,2005,15(10):1177-1180.
Authors:JIN Yang  XIN Jian-bao  FU Ling  ZHANG Jian-chu  LI Yuan-gui  BAI Ming
Institution:Union Hospital of Tongji Medical College, Huazhong University of Science and Technology. Wuhan 430022,China
Abstract:OBJECTIVE To evaluate the efficacy and safety of meropenem on the treatment of hospital acquired infection.METHODS Patients with hospital acquired infection were selected,from them 33 patients were in trial group and 31 patients in control group.A regimen of meropenem 0.5 g,q8h for 7-10 d was given in the trial group and imipenem/cilastatin(Tienam) 1.0 g,q8h for 7-10 d in the control group.RESULTS The cured rate,effective rate,and bacterial clearance rate were 48.5%,81.8%,and 90.0% in meropenem group and 54.8%,87.1%,and 86.4% in Tienam group,respectively.The incidences of adverse reaction of them were 9.1% and 6.5%.There was no significant difference about these parameters between them.CONCLUSIONS Meropenem is an effective and safe antibiotic for treatment of hospital acquired infection as well as Tienam.
Keywords:Meropenem  Treatment  Hospital acquired infection
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号